{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T13:47:39Z","timestamp":1785764859958,"version":"3.56.0"},"reference-count":9,"publisher":"Ovid Technologies (Wolters Kluwer Health)","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:p>\n                    A 50-year-old man with weight loss and fatigue was diagnosed with a grade 2 liver-metastatic neuroendocrine tumor (NET). Dual-tracer molecular imaging was performed for staging and characterization. While\n                    <jats:sup>18<\/jats:sup>\n                    F-FDG PET\/CT showed focal high uptake in a gallbladder lesion (SUVmax: 10) and non-FDG-avid liver metastases,\n                    <jats:sup>68<\/jats:sup>\n                    Ga-DOTATATE PET\/CT revealed intense somatostatin receptor expression in the primary pancreatic lesion and liver metastases, but no uptake in the gallbladder. This discordant \u201cflip-flop\u201d pattern typically suggests high-grade dedifferentiation. However, histopathology following cholecystectomy revealed a low-grade intracholecystic papillary neoplasm (ICPN). This case highlights that discordant FDG-positive\/SSTR-negative foci in NET patients can represent rare premalignant mimics rather than aggressive tumor biology.\n                  <\/jats:p>","DOI":"10.1097\/rlu.0000000000006476","type":"journal-article","created":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T13:05:47Z","timestamp":1785762347000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Intracholecystic Papillary Neoplasm Mimicking High-Grade Dedifferentiation in a Patient With Neuroendocrine Tumor: The Value of Dual-Tracer PET\/CT"],"prefix":"10.1097","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-6010-3899","authenticated-orcid":false,"given":"Caner","family":"Simsir","sequence":"first","affiliation":[{"name":"Department of Nuclear Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerem","family":"Y\u0131lmaz","sequence":"additional","affiliation":[{"name":"Department ofPathology, Hacettepe University Faculty of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saadettin","family":"K\u0131l\u0131\u00e7kap","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Liv Hospital Ankara"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruhi Mehmet","family":"Onur","sequence":"additional","affiliation":[{"name":"Department of Radiology, Hacettepe University Faculty of Medicine, Ankara, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murat","family":"Tuncel","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,7,10]]},"reference":[{"key":"R1-20260803","first-page":"305","article-title":"Dual somatostatin receptor and FDG PET\/CT imaging in metastatic neuroendocrine tumours","volume":"105","author":"Chan","year":"2017","journal-title":"Neuroendocrinology"},{"key":"R2-20260803","first-page":"1646","article-title":"18F-FDG PET is superior to WHO grading as a prognostic tool in neuroendocrine neoplasms","volume":"51","author":"Binderup","year":"2010","journal-title":"J Nucl Med"},{"key":"R3-20260803","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1097\/PAS.0b013e318262787c","article-title":"Intracholecystic papillary-tubular neoplasms (ICPN) of the gallbladder","volume":"36","author":"Adsay","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"R4-20260803","first-page":"3083","article-title":"Synchronous and metachronous malignancies in patients with neuroendocrine neoplasms","volume":"13","author":"Tsoli","year":"2021","journal-title":"Cancers (Basel)"},{"key":"R5-20260803","first-page":"220","article-title":"18F-FDG PET\/CT can predict the tumor grade of gastroenteropancreatic neuroendocrine tumors","volume":"36","author":"Panagiotidis","year":"2015","journal-title":"Nucl Med Commun"},{"key":"R6-20260803","first-page":"938","article-title":"The prognostic value of 18F-FDG PET\/CT in pancreatic neuroendocrine tumors","volume":"35","author":"Abdulrezzak","year":"2014","journal-title":"Nucl Med Commun"},{"key":"R7-20260803","first-page":"8756","article-title":"Intracholecystic papillary neoplasm of the gallbladder: a case report","volume":"10","author":"Wan","year":"2022","journal-title":"World J Clin Cases"},{"key":"R8-20260803","first-page":"113","article-title":"Intracholecystic papillary neoplasm of the gallbladder: a case report","volume":"6","author":"Ohgi","year":"2020","journal-title":"Surg Case Rep"},{"key":"R9-20260803","first-page":"e402","article-title":"68Ga-DOTATATE PET\/CT for staging of gallbladder neuroendocrine carcinomas","volume":"40","author":"Sharma","year":"2015","journal-title":"Clin Nucl Med"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/RLU.0000000000006476","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T13:05:49Z","timestamp":1785762349000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/RLU.0000000000006476"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,10]]},"references-count":9,"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000006476","relation":{},"ISSN":["0363-9762","1536-0229"],"issn-type":[{"value":"0363-9762","type":"print"},{"value":"1536-0229","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,10]]},"assertion":[{"value":"2026-01-03","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-03-13","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}